BOSTON and ANDOVER, Mass., Feb. 12, 2014 /PRNewswire/ -- Partners HealthCare At Home has selected Royal Philips (NYSE: PHG, AEX: PHIA) to support its growing telemonitoring services, providing improved clinical oversight for newly discharged patients and those with chronic conditions, such as congestive heart failure. With this enhanced care, Partners HealthCare At Home nursing staff can remotely monitor a patient's health by tracking vital signs and intervening earlier with medical attention, successfully reducing the rate of costly hospital readmissions.
"Remote patient monitoring does more than improve care coordination," says Sue Beausoliel, vice president of operations at Partners HealthCare at Home. "It provides a tool for patients to actively engage in their own health management. As the healthcare industry focuses more on improving patient experience and outcomes while reducing costs, technologies such as home monitoring contribute toward improved quality of life. Instead of having to wait for the next appointment, this real-time data daily monitoring helps us connect with patients, track their health status, alert us to a problem and intervene earlier before it becomes full blown."
The agency has already demonstrated positive results with telemonitoring through its Chronic Cardiac Care program. Since 2006, PHH has served 1,200 heart failure patients through this program and found a 50 percent reduction in readmission rates for enrolled patients, with an estimated savings of $10 million in health care costs.
Partners selected Philips as its telemonitoring partner based on its proven track record in implementing their other home based innovative clinical programs — Lifeline and Medication Dispensing — for PHH patients. These services transform the way care is delivered by creating the shortest path to the best care, from hospital to the home. Developed in collaboration with clinicians and health systems, Philips' hospital to home programs equip providers with a range of tools and services that lay the foundation for long-term success with telehealth.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts